K-ras exon 2 point mutations in human endometrial cancer

Cancer Letters

Volumn 164, Issue 2, 2001, Pages 207-212

  Semczuk, Andrzej ^a   Schneider Stock, Regine ^c   Berbec, Henryk ^a   Marzec, Barbara ^b   Jakowicki, Jerzy A ^a   Roessner, Albert ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b University of Medicine at Lublin   (Poland)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Carcinosarcoma; Endometrial cancer; K ras; Point mutation; Rb

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CODON; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFECT; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

AGED; CODON; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; EXONS; FEMALE; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 0035953188     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00380-9     Document Type: Article

References (32)

1. ras genes
2. The oncogene and tumour suppressor gene
3. Whats new in ras genes? Physiological role of ras genes in signal transduction and significance of ras gene activation in tumorigenesis
4. Proteins regulating ras and its relatives
5. GTPase activating proteins
6. ras oncogenes in human cancer: A review
7. The ras gene family and human carcinogenesis
8. Detection of K-ras mutations in cancerous lesions of human endometrium
9. K-ras activation in human endometrial carcinomas detected by PCR-ACRS method: A preliminary result
10. K-ras gene point mutations in human endometrial carcinomas: Correlation with clinicopathological features and patients outcome
11. Mutations and amplification of oncogenes in endometrial cancer
12. Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability
13. FIGO stages, 1988 revision
14. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
15. Clinopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors
16. Analysis of the variable number of tandem repeats locus D1S80 by the polymerase chain reaction followed by high resolution polyacrylamide gel electrophoresis
17. Silver staining of DNA in polyacrylamide gels: Linearity and effect of fragment size
18. RB protein expression in human endometrial carcinomas: An immunohistochemical study
19. Mutations of ras genes in human tumours
20. Molecular events in endometrial carcinogenesis
21. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado
22. K-ras activation in premalignant and malignant epithelial lesions of the human uterus
23. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium
24. Mutations of the Ki-ras oncogene in endometrial carcinoma
25. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas
26. Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: A clinicopathologic and molecular comparison
27. The multistep nature of cancer
28. ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
29. Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma
30. p27 and D1 abnormalities in uterine papillary serous carcinoma